XML 17 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Operations - USD ($)
 3 Months Ended 10 Months Ended 12 Months Ended
Dec. 31, 2016
Oct. 26, 2016
Dec. 31, 2017
NeuroOne LLC      
Operating expenses:      
General and administrative   $ 6,657  
Research and development    
Total operating expenses   6,657  
Loss from operations   (6,657)  
Interest expense   (11,947)  
Loss on convertible notes and short-term notes extinguishment, net    
Net loss   $ (18,604)  
Successor      
Operating expenses:      
General and administrative $ 182,667   $ 2,336,988
Research and development   735,333
Total operating expenses 182,667   3,072,321
Loss from operations (182,667)   (3,072,321)
Interest expense (83,297)   (1,395,138)
Net change in fair value for the warrant liability and premium conversion derivative (406)   (240,053)
Loss on convertible notes and short-term notes extinguishment, net   (350,914)
Net loss $ (266,370)   $ (5,058,426)
Net loss per share:      
Basic and diluted $ (0.06)   $ (0.77)
Number of shares used in per share calculations:      
Basic and diluted 4,421,092   6,610,072